Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fathia Mami-Chouaib

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|June 14, 2019
Editorial: Tissue Resident Memory T CellsFathia Mami-Chouaib, Eric Tartour
STAR Protocols|January 25, 2021
Isolation of tumor-resident CD8<sup>+</sup> T cells from human lung tumorsStéphanie Corgnac, Yann Lecluse, Fathia Mami-Chouaib
Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promisesMohamad Omar Ashi, Fathia Mami-Chouaib, Stéphanie Corgnac
Annals of the New York Academy of Sciences|January 11, 2013
TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytesFaten El Hage, Aurélie Durgeau, Fathia Mami-Chouaib
Clinical Immunology (Orlando, Fla.)|November 18, 2008
Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancerSalem Chouaib, Franck Meslin, Jerôme Thiery, et al.
Frontiers in Immunology|February 7, 2018
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer ImmunotherapyAurélie Durgeau, Yasemin Virk, Stéphanie Corgnac, et al.
Frontiers in Immunology|August 7, 2023
Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapyIsabelle Damei, Tatiana Trickovic, Fathia Mami-Chouaib, et al.
Oncoimmunology|March 14, 2013
T-cell modulatory properties of CD5 and its role in antitumor immune responsesMouna Tabbekh, M'barka Mokrani-Hammani, Georges Bismuth, et al.
Medecine Sciences : M/S|September 12, 2006
[Immunotherapy of cancer: promise and reality]Salem Chouaib, Faten El Hage, Houssem Benlalam, et al.
Cancer Research|December 11, 2012
Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune responseKatarzyna Franciszkiewicz, Alexandre Boissonnas, Marie Boutet, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|June 14, 2019
Editorial: Tissue Resident Memory T CellsFathia Mami-Chouaib, Eric Tartour
STAR Protocols|January 25, 2021
Isolation of tumor-resident CD8<sup>+</sup> T cells from human lung tumorsStéphanie Corgnac, Yann Lecluse, Fathia Mami-Chouaib
Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promisesMohamad Omar Ashi, Fathia Mami-Chouaib, Stéphanie Corgnac
Annals of the New York Academy of Sciences|January 11, 2013
TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytesFaten El Hage, Aurélie Durgeau, Fathia Mami-Chouaib
Clinical Immunology (Orlando, Fla.)|November 18, 2008
Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancerSalem Chouaib, Franck Meslin, Jerôme Thiery, et al.
Frontiers in Immunology|February 7, 2018
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer ImmunotherapyAurélie Durgeau, Yasemin Virk, Stéphanie Corgnac, et al.
Frontiers in Immunology|August 7, 2023
Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapyIsabelle Damei, Tatiana Trickovic, Fathia Mami-Chouaib, et al.
Oncoimmunology|March 14, 2013
T-cell modulatory properties of CD5 and its role in antitumor immune responsesMouna Tabbekh, M'barka Mokrani-Hammani, Georges Bismuth, et al.
Medecine Sciences : M/S|September 12, 2006
[Immunotherapy of cancer: promise and reality]Salem Chouaib, Faten El Hage, Houssem Benlalam, et al.
Cancer Research|December 11, 2012
Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune responseKatarzyna Franciszkiewicz, Alexandre Boissonnas, Marie Boutet, et al.
Pageof 9